Aktia Bank Plc
Aktia Bank Plc
Stock Exchange Release
5 January 2021 at 3.30 p.m.
Aktia Bank Plc: Managers’ Transactions – Outi Henriksson
Person subject to the notification requirement
Name: Henriksson, Outi
Position: Chief Financial Officer
Issuer: Aktia Bank plc
LEI: 743700GC62JLHFBUND16
Notification type: INITIAL NOTIFICATION
Reference number: 743700GC62JLHFBUND16_20210105095650_46
____________________________________________
Transaction date: 2021-01-04
Venue not applicable
Instrument type: SHARE
ISIN: FI4000058870
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 3,015 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 3,015 Volume weighted average price: 0.00 EUR
Aktia Bank Plc
Further information:
Lotta Borgström, Director, Investor Relations and Communications, tel. +358 10 247 6838, lotta.borgstrom@aktia.fi
Distribution:
Nasdaq Helsinki Ltd
Mass media
www.aktia.com
Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsinki, Turku, Tampere, Vaasa and Oulu regions. Our award-winning asset management business sells investment funds internationally. We employ approximately 750 people around Finland. Aktia's assets under management (AuM) on 31 December 2019 amounted to EUR 9.9 billion, and the balance sheet total was EUR 9.7 billion. Aktia's shares are listed on Nasdaq Helsinki Ltd (AKTIA). aktia.com.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG22.10.2025 07:15:00 CEST | Press release
Novartis Cosentyx® meets primary and all secondary endpoints in Phase III trial in patients with polymyalgia rheumatica (PMR)
Ipsen Pharma22.10.2025 07:05:00 CEST | Press release
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
HEINEKEN Holding NV22.10.2025 07:01:00 CEST | Press release
Heineken Holding N.V. reports on 2025 third quarter trading
A2Mac122.10.2025 07:00:00 CEST | Press release
A2MAC1 and ZeBeyond partner to bring Simulation-First Powertrain Benchmarking to market
Sanofi Winthrop Industrie22.10.2025 07:00:00 CEST | Press release
Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom